Researchers reveal how Microsoft Copilot can be manipulated by prompt injection attacks to generate convincing phishing messages inside trusted AI summaries.

Virtue AI today announced Agent ForgingGround with Built-In Red-Teaming Agents, the first enterprise-scale testing ground designed to continuously evaluate and stress-test AI agents (including ...

Opsera, the leader in Agentic DevOps, today announced the launch of Opsera AI Agents for DevSecOps, a suite of intelligent, purpose-built agents designed to help enterprises transition from ...

Building an open-source data lakehouse costs $520K/year in engineering time, before licenses and infra. The real all-in cost ...

The moment an AI system can read internal systems, trigger workflows, move money, send emails, update records or approve ...

In this tutorial, we build a production-ready agentic workflow that prioritizes reliability over best-effort generation by enforcing strict, typed outputs at every step. We use PydanticAI to define ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. This article introduces practical methods for ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Forbes contributors publish independent expert analyses and insights. Victor Dey is an analyst and writer covering AI and emerging tech. This voice experience is generated by AI. Learn more. This ...

Databricks Inc.’s 2026 State of AI Agents report, released today, documents rapid growth in the use of artificial intelligence agents within enterprises but acknowledges that few are deploying the ...

Enterprises are moving beyond AI pilots and chatbots, with multi-agent systems increasingly deployed to run real business workflows at scale. Enterprises are entering a new phase of AI adoption, ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...